A consensus statement from the Society for Perioperative Assessment and Quality Improvement recommends patients should ...

Delhi High Court bars Dr Reddy's and OneSource from selling semaglutide in India, supporting Novo Nordisk's patent rights as ...

Vivani Medical is developing GLP-1 subdermal implants that aim to provide a consistent therapeutic dose for six months, and ...

Over two thirds of patients with hidradenitis suppurativa experience fewer flares, new lesions, and improved quality of life while using GLP-1 receptor agonists.

The study reveals essential insights on the basis of the Drug Type (Semaglutide, Liraglutide, Dulaglutide, Exenatide, Others), Route of Administration (Oral, Injectable), Indication (Type 2 Diabetes, ...

If you’re struggling with weight, you’re not alone. Around 42 percent of American adults have obesity. In addition to ...

Lilly and others are trying to develop oral therapies to complement current drugs – Novo Nordisk's Wegovy (semaglutide ... GLP-1 agonist Trulicity (dulaglutide). Shares in Lilly were up nearly ...

People using GLP-1 drugs like Ozempic are reporting "Ozempic teeth," an unusual side effect impacting dental health. "Ozempic ...

Surgery risks have been highlighted in a new warning for users of popular diabetes and weight-loss drugs, including Ozempic ...

The court’s intervention comes at a crucial time as Novo Nordisk gears up for the rollout of Wegovy, amid rising global ...

Medicare Part D plans and some Part C plans may cover Trulicity (dulaglutide) for diabetes, but the exact coverage depends on the plan. Such plans will only cover this drug for weight loss in ...